Reviewing Notable Labs (NASDAQ:NTBL) & Roivant Sciences (NASDAQ:ROIV)

Notable Labs (NASDAQ:NTBLGet Free Report) and Roivant Sciences (NASDAQ:ROIVGet Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.

Earnings and Valuation

This table compares Notable Labs and Roivant Sciences’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Notable Labs $311,000.00 6.46 -$11.26 million N/A N/A
Roivant Sciences $124.79 million 68.58 $4.35 billion $5.06 2.10

Roivant Sciences has higher revenue and earnings than Notable Labs.

Volatility & Risk

Notable Labs has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Roivant Sciences has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500.

Insider and Institutional Ownership

70.5% of Notable Labs shares are held by institutional investors. Comparatively, 64.8% of Roivant Sciences shares are held by institutional investors. 1.2% of Notable Labs shares are held by insiders. Comparatively, 4.6% of Roivant Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Notable Labs and Roivant Sciences’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Notable Labs N/A -54.54% -43.40%
Roivant Sciences 3,484.86% -25.05% -20.98%

Analyst Recommendations

This is a summary of current ratings for Notable Labs and Roivant Sciences, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Notable Labs 0 0 2 0 3.00
Roivant Sciences 0 1 9 0 2.90

Notable Labs presently has a consensus target price of $7.00, suggesting a potential upside of 673.48%. Roivant Sciences has a consensus target price of $16.90, suggesting a potential upside of 59.13%. Given Notable Labs’ stronger consensus rating and higher probable upside, equities research analysts plainly believe Notable Labs is more favorable than Roivant Sciences.

Summary

Roivant Sciences beats Notable Labs on 9 of the 12 factors compared between the two stocks.

About Notable Labs

(Get Free Report)

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox, a pro-drug of ciclopirox for acute myeloid leukemia. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California.

About Roivant Sciences

(Get Free Report)

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. It develops VTAMA, a novel topical for the treatment of psoriasis and atopic dermatitis; batoclimab and IMVT-1402, the fully human monoclonal antibodies targeting the neonatal Fc receptor across various IgG-mediated autoimmune indications; and RVT-3101, an anti-TL1A antibody for ulcerative colitis and Crohn's disease. The company was founded in 2014 and is based in London, the United Kingdom.

Receive News & Ratings for Notable Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Notable Labs and related companies with MarketBeat.com's FREE daily email newsletter.